Delivery Order SPE2DB20D2104-SPE2DB25FMKYD
Award Date 3/12/25
Potential Completion Date 3/13/25
Potential Value $1.4K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,695.23, is for the delivery of Ondansetron ODT 4 mg tablets. This is a firm-fixed-price delivery order contract with a completion date of January 23, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,007.98, is for the delivery of Ondansetron ODT 4 mg tablets. It is a firm fixed-price delivery order contract with a period of performance through February 7, 2025. The contract is not set aside for any specific business type. Amerisourcebergen holds a significant Indefinite Delivery Contract...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,078.81, is for the delivery of Ondansetron ODT 4 mg tablets. It is a firm fixed-price delivery order contract with a completion date of February 24, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $17,316.57, is for the delivery of Ondansetron ODT 4 mg tablets. The contract has an ultimate completion date of June 12, 2024 and is a firm fixed-price delivery order. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA,...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,077.90, is for the delivery of Ondansetron ODT 4 mg tablets. It is a firm fixed-price delivery order contract with a completion date of May 5, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00....
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of Ondansetron ODT 4 mg Tablets. The contract has a ceiling value of $10,163.92 and is a firm fixed price Delivery Order contract, with a performance period ending on June 25, 2025. The contract is not set aside for any particular business category. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,888.08, is for the delivery of Ondansetron ODT 4 mg tablets. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 2, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $2,742.47, is for the delivery of Ondansetron ODT 4 mg tablets. The contract has an ultimate completion date of January 15, 2025 and is a firm fixed-price Delivery Order. This award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,997.57 firm fixed-price delivery order is for the supply of 4,567,760 units of Ondansetron ODT 4 mg tablets. The contract has an ultimate completion date of April 2, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. It is a delivery order under the company's existing Indefinite Delivery Contract (IDC) with the DLA valued at $999,999,999. The contract covers the supply of 4,566,719,877 units of the generic drug Ondansetron ODT 4 mg tablets in 30-count packages. This is a firm fixed-price contract with a ceiling value of $2,677.43 and a completion date...